Exelixis
EXEL
#1845
Rank
C$15.18 B
Marketcap
C$56.42
Share price
-2.18%
Change (1 day)
16.59%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) Fails to deliver data

Key failure to deliver metrics for Exelixis:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Exelixis (EXEL) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Exelixis (EXEL) - since 2013

Volume in USD (price x number of shares), data since 2013

Exelixis (EXEL) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026C$3.19 M-87.13%
2025C$24.8 M105.32%
2024C$12.08 M86.29%
2023C$6.48 M-41.81%
2022C$11.14 M-31.9%
2021C$16.36 M-20.71%
2020C$20.64 M303.63%
2019C$5.11 M-70.5%
2018C$17.33 M8.82%
2017C$15.92 M-17.35%
2016C$19.27 M-75.68%
2015C$79.23 M19.37%
2014C$66.37 M258.49%
2013C$18.51 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
C$24.94 MC$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$56.21 MC$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$0.20 BC$0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.89 MC$69.64 M๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$36.21 MC$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$31.05 MC$81.93 M๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$48.95 MC$0.36 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
C$0.23 MC$1.17 M๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
N/AC$0.04 M๐Ÿ‡บ๐Ÿ‡ธ USA